The device was not returned for analysis.The reported patient effect of ischemia is listed in the absolute pro ll instruction for use as a known potential adverse event.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents from this lot.An abbott vascular medical affairs expert reviewed the details of the case and the angiographic images provided.The distal stent of the absolute pro ll 6.0 x 120 mm is stretched, and the marker beads of the distal stent indicate that there is some twisting of the stent.The probable cause is undetermined but pulling back on the whole system during deployment can contribute to this type of deployment.There are no images of the full deployment to confirm.The investigation was unable to determine a cause for the reported stent damage during deployment causing poor wall apposition and reduced blood flow.It may be possible that the delivery system was moved or repositioned during deployment causing the stent to stretch, fracture and/or twist in the vessel; however, this could not be confirmed.The reported resistance during advancement was likely due to the challenging anatomy, which was described as heavily calcified.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
|